EMvision Research Notes, page-11

@SuperWealthy It was priced fairly reasonable going into the IPO and as you would have read in the other threads the top 20 is very tight, also there are a large amount of shares still under escrow. EMV's addressable markets for both the Brain Scanner and Torso Scanner are quite big. I'd say there are a lot of investors just getting set early on this one, and I am one of them. Some potential news flow in the future could look like:

- Conclusion of Healthy Human Trials for the Brain Scanner. This is a given as I believe the scanner emits less radiation than a mobile phone.

- Update on timeline for Clinical Trials at PAH.

- Potential updates on progress with Torso Scanner prototype.

- Potential announcements with regards to MOUs / Trial Partnerships etc are not out of the question considering Ron & Stuart's contacts but more likely to happen down the track.

Obviously DYOR but good luck to all investors.